Company / Profit Margin
Oncology Institute, Inc. Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-16.4%
FY2025
5-year range
-25.6% / 0.1%
FY2021-FY2025
Trend
+35.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 0.1% to -16.4% over the past 2 years.
Based on SEC 10-K filings.
-16.4% in FY2025 with a 3-year CAGR of -11.1%.
Declined from 0.1% to -16.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -11.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 35.8% year-over-year.
- Peak profit margin was recorded in FY2023.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -16.4% | +35.8% |
| FY2024 | -25.6% | -42800.0% |
| FY2023 | 0.1% | +101.1% |
| FY2022 | -5.4% | +29.6% |
| FY2021 | -7.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026